| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $-0.41 (Miss by $-0.03) |
| EPS GAAP Actual | $-0.41 (Miss by $-0.03) |
| Revenue Actual | $0.000348B |
| Revenue Surprise | Beat by $0.348M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.25124 |
| EPS GAAP Estimate | $-0.25124 |
| Revenue Estimate | $0.00027025B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.37647 | 25.44 | 0.17155 | 2.58139 | 5 |
| Dec 2028 | -0.18415 | -190.17 | -0.31839 | -0.11393 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.61 | -0.32064 | 0.000348B | -8265.23% | -0.57M |
| FQ2 2025 (Jun 2025) | -0.15 | 0.21313 | 0.019145B | 88.1% | 17.52M |
| FQ1 2025 (Mar 2025) | -0.34 | -0.34 | 0.002978B | 100% | 2.98M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.012772B | 87.52% | 12.77M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0.029111B | 93.55% | 29.11M |
| FQ3 2023 (Sep 2023) | -0.56 | -0.56 | 0.0018773B | 100% | 1.88M |
| FQ4 2023 (Dec 2023) | -0.52 | -0.52 | 0.00159455B | 100% | 1.59M |
| FQ1 2022 (Mar 2022) | 0.0705 | 0.0705 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.25124
Consensus Revenue Estimates
0.00027025B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.44367 | -- | -0.44896 | -0.43838 | 5 |
| FQ3 2027 (Sep 2027) | -0.60647 | -- | -0.60647 | -0.60647 | 1 |
| FQ2 2027 (Jun 2027) | -0.69709 | -- | -0.69709 | -0.69709 | 1 |
| FQ1 2027 (Mar 2027) | -0.61404 | -- | -0.61404 | -0.61404 | 1 |
| FQ4 2026 (Oct 2026) | -0.28843 | -- | -0.50943 | -0.06742768 | 1 |
| FQ3 2026 (Jul 2026) | -0.26615 | -129.19 | -0.47008 | -0.06221917 | 1 |
| FQ2 2026 (Jun 2026) | -0.25211 | 40.5 | -0.45733 | -0.04688775 | 2 |
| FQ1 2026 (Mar 2026) | -0.25124 | -35.33 | -0.45575 | -0.04672594 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.01B | -- | 0.01B | 0.01B | 3 |
| FQ3 2027 (Sep 2027) | 0.01B | -- | 0.01B | 0.01B | 2 |
| FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 2 |
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 2 |
| FQ4 2026 (Oct 2026) | 0B | -- | 0B | 0B | 1 |
| FQ3 2026 (Jul 2026) | 0B | 35.62 | 0B | 0B | 1 |
| FQ2 2026 (Jun 2026) | 0B | -3442.09 | 0B | 0B | 4 |
| FQ1 2026 (Mar 2026) | 0B | -1001.94 | 0B | 0B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
4
EPS # of in-lines
2
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.28936 | -0.61 | -0.32064 | 52.56% |
| FQ2 2025 (Jun 2025) | -0.36313 | -0.15 | 0.21313 | -142.09% |
| FQ1 2025 (Mar 2025) | -0.34 | -0.34 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ3 2023 (Sep 2023) | -0.56 | -0.56 | 100% | |
| FQ4 2023 (Dec 2023) | -0.52 | -0.52 | 100% | |
| FQ1 2022 (Mar 2022) | 0.0705 | 0.0705 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $-0.57M | -164.62% |
| FQ2 2025 (Jun 2025) | $0B | $0.02B | $17.52M | 91.49% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $2.98M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.01B | $12.77M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.03B | $29.11M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $0B | $1.88M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $1.59M | 100% |
| FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |